- NOK370.92m
- NOK436.01m
- NOK531.44m
- 76
- 47
- 23
- 44
Annual balance sheet for Navamedic ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 39.6 | 52.6 | 65.4 | 38.3 | 53.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 36.3 | 91 | 98.5 | 65.5 | 64.6 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 118 | 205 | 244 | 210 | 200 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.08 | 8.31 | 7.12 | 9.75 | 8.74 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 260 | 330 | 383 | 524 | 491 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 105 | 136 | 126 | 189 | 141 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 131 | 179 | 173 | 302 | 251 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 129 | 151 | 210 | 222 | 240 |
Total Liabilities & Shareholders' Equity | 260 | 330 | 383 | 524 | 491 |
Total Common Shares Outstanding |